Tradestie Institutional Equity Comparison Engine

IONS vs PTCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTCT Overall Edge

PTCT Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PTC Therapeutics, Inc. (PTCT) driven by superior Valuation, Growth & Margin, Momentum & Technical while IONS counters with relative strength in Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus PTCT at 19.9x Forward P/E and 21.5% operating margin (+69.6% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against PTCT sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTCT
IONS 90.9x vs PTCT 19.9x Fwd P/E
Growth & Margin Winner PTCT
Op Margin -58.8% vs 21.5% ยท YoY +54.9% vs +69.6%
Momentum & Technical Winner PTCT
1Y -59.1% vs -17.8% ยท 52W Pos 2% vs 9%
Options & Structure Winner IONS
BREAKDOWN (17th %ile IV) vs BREAKDOWN (17th %ile IV)
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0
PTCT NASDAQ
PTC Therapeutics, Inc.
Pharmaceutical Preparations
$61.62
-2.95% 1D
Market Cap $5.3B
1M Return +4.02%
1Y Return -17.79%
Forward P/E 19.9x
Unified AI Score
45.4 / 100 HOLD
Tech 48.0 Fund 54.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IONS -59.1% PTCT -17.79% Spread: +41.31 pp (PTCT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IONS Revenue PTCT Revenue IONS Op. Margin PTCT Op. Margin Margin Edge
FY2018 $600M $260M -10.2% -43.7% IONS
FY2019 $1.12B $310M 32.6% -78.6% IONS
FY2020 $730M $380M -23.6% -113.4% IONS
FY2021 $810M $540M -3.7% -69.5% IONS
FY2022 $590M $700M -69.8% -64.0% PTCT
FY2023 $790M $940M -44.9% -46.9% IONS
FY2024 $710M $810M -67.4% -37.5% PTCT
FY2025 $940M $1.73B -40.4% 50.1% PTCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IONS (2) vs PTCT (8)
Institutional Metric IONS PTCT Criterion Row Winner
Market Capitalization Scale $4.7B $5.3B Larger Scale PTCT
Trailing P/E Ratio Valuation 90.9x 19.4x Lower Multiple PTCT
Forward P/E Ratio Valuation 90.9x 19.9x Lower Multiple PTCT
Revenue Growth (YoY) Growth +54.9% +69.6% Higher Growth PTCT
Operating Margin (TTM) Profitability -58.8% 21.5% Higher Margin PTCT
Net Profit Margin Profitability -56.9% -9.2% Higher Margin PTCT
Return on Equity (ROE) Capital Efficiency -108.0% -7740.1% Higher ROE IONS
52-Week Range Position Momentum 2% ($27โ€“$87) 9% ($59โ€“$91) Stronger Trend PTCT
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 86% Vol 0.81ฮฒ ยท 58% Vol Lower Realized Risk PTCT
Unified Institutional Score Composite Signal 63.9 / 100 (BUY) 45.4 / 100 (HOLD) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IONS vs PTCT Buy Guide
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTCT BREAKDOWN
91d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live PTCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IONS nor PTCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.